Quick Answer
CANNAPHARMARX, INC. reported R&D Expense of $324.1 thousand for fiscal year 2014.
CANNAPHARMARX, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2014 | $324.1K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2015 | $145.8K | +7.9% | -9.8% |
| June 30, 2015 | $161.7K | +334.7% | +0.5% |
| March 31, 2015 | $160.8K | — | +19.0% |
| September 30, 2014 | $135.1K | — | +263.2% |
| June 30, 2014 | $37.2K | — | — |
- The most recent figure is from CANNAPHARMARX, INC.’s fiscal year 2014 report (Form 10-K), filed with the SEC on March 31, 2015.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: